ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2018

Abstract Number: 1275

Dual-Energy CT for the Diagnosis of Gout: A Prospective Study in Patients with No Prior History of Gout

Mihaela Gamala1, Johannes W. G. Jacobs2, Suzanne Linn-Rasker3, Maarten Nix4, Ben Heggelman4, Pieternel Pasker5, Jacob van Laar6 and Ruth Klaasen3, 1Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 2Rheumatolgy & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 3Rheumatology, Meander Medical Center Amersfoort, Amersfoort, Netherlands, 4Radiology, Meander Medical Center Amersfoort, Amersfoort, Netherlands, 5Meander Academy, Meander Medical Center Amersfoort, Amersfoort, Netherlands, 6Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, the Netherlands, Utrecht, Netherlands

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2018

Keywords: gout

Session Information

Date: Monday, October 22, 2018

Title: Metabolic and Crystal Arthropathies – Basic and Clinical Science Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Gout is associated with joint damage, and increased cardiovascular morbidity, so to diagnose and treat gout early is important. However, joint aspiration and microscopy not always yield the diagnosis. The latest diagnostic technique to visualize monosodium uric acid (MSU) depositions is Dual Energy CT scan (DECT).1

We purpose to assess the sensitivity and specificity of DECT for diagnosing gout in patients with unclassified arthritis.

Methods: We included 87 consecutive patients with acute mono or oligo arthritis without prior gout diagnosis who presented to the outpatient clinic of the Department of Rheumatology of Meander Medical Centre, Amersfoort, the Netherlands, ClinicalTrials.gov number NCT03038386. Seven patients dropped out, see Figure. Patients underwent aspiration of the arthritic joint for the detection of MSU crystals (see Table) and a DECT scan of hands and wrists, knees, ankles and feet. The synovial fluid result for MSU crystals was the gold standard for gout.

Results: For demographic and clinical characteristics of the patients see Table, and for study data and outcomes see Figure. The sensitivity and specificity of DECT for gout deposition in the index joint were 0.58 (95% CI 0.43-0.72) and 0.75 (95% CI 0.57-0.89), respectively, with an area under the ROC curve of 0.67 (95% CI 0.55-0.79), p<0.05. When classifying DECT as positive if deposition was observed at the index joint and/or in other locations, sensitivity was higher: 0.77 (95% CI 0.63-0.88), but specificity lower: 0.69 (95% CI 0.48-0.86).

Conclusion: These preliminary data show the diagnostic value of DECT in patients with acute unclassified mono or oligo arthritis. Probably, DECT sensitivity is underestimated by false negative MSU results due to a sampling error, because of incorrect aspiration, or extra-articular locations of the gout, e.g. around tendons.

Table. The demographic and clinical characteristics of the patients (n=80) included in the study

Patients MSU positive (n=48)

Patients MSU negative (n=32)

Age in years, mean (SD),

59.0 (15.6)

63.1 (13.0)

Sex, N (%)

   Male

41   (85.4)

25   (78.1)

   Female

7    (14.6)

7    (21.9)

Arthritic joint aspirated (N, %)

   MTP1

29   (60.4)

6    (18.8)

   Other joints

19   (39.6)

26   (81.2)

Period between 1th arthritis attack and baseline visit in months, median (IQR)*

12 (56)

6 (35.8)

Serum uric acid (µmol/L) mean (SD)

465.72  (120.65)

403.50  (109.71)

* according to patient


Disclosure: M. Gamala, None; J. W. G. Jacobs, None; S. Linn-Rasker, None; M. Nix, None; B. Heggelman, None; P. Pasker, None; J. van Laar, Arthrogen, MSD, Pfizer, Eli Lelly, BMS, Astra Zeneca, Roche-Genentech, 2, 5; R. Klaasen, None.

To cite this abstract in AMA style:

Gamala M, Jacobs JWG, Linn-Rasker S, Nix M, Heggelman B, Pasker P, van Laar J, Klaasen R. Dual-Energy CT for the Diagnosis of Gout: A Prospective Study in Patients with No Prior History of Gout [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/dual-energy-ct-for-the-diagnosis-of-gout-a-prospective-study-in-patients-with-no-prior-history-of-gout/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dual-energy-ct-for-the-diagnosis-of-gout-a-prospective-study-in-patients-with-no-prior-history-of-gout/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology